Tagged: lombar

0

Percutaneous Vertebral Augmentation for Vertebral Compression Fractures: National Trends in the Medicare Population (2005-2015).

Spine (Phila Pa 1976). 2019 Jan 15;44(2):123-133. doi: 10.1097/BRS.0000000000002893. Percutaneous Vertebral Augmentation for Vertebral Compression Fractures: National Trends in the Medicare Population (2005-2015). Rabei R1, Patel K2, Ginsburg M3, Patel MV4, Turba UC2, Arslan B2, Ahmed O2. Author information Abstract STUDY DESIGN: Retrospective analysis...

0

Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.

Cochrane Database Syst Rev. 2018 Nov 6;11:CD006349. doi: 10.1002/14651858.CD006349.pub4. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Buchbinder R1, Johnston RV, Rischin KJ, Homik J, Jones CA, Golmohammadi K, Kallmes DF. Author information Abstract BACKGROUND: Percutaneous vertebroplasty remains widely used to treat osteoporotic vertebral fractures although...

0

Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial.

BMJ. 2018 May 9;361:k1551. doi: 10.1136/bmj.k1551. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. Firanescu CE1, de Vries J2,3, Lodder P3, Venmans A2, Schoemaker MC2, Smeets AJ, Donga E2, Juttmann JR2, Klazen CAH4, Elgersma OEH5, Jansen...

0

Hyperacute management of intracerebral haemorrhage

Clin Med (Lond). 2018 Apr 1; 18(Suppl 2): s9–s12. doi: 10.7861/clinmedicine.18-2s-s9 PMCID: PMC6334033 PMID: 29700086 Hyperacute management of intracerebral haemorrhage Kyriaki Paroutoglou, consultant stroke physicianA and Adrian R Parry-Jones, NIHR clinician scientist and honorary consultant neurologistB Author information Copyright and License information Disclaimer...

0

Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial.

Neurocrit Care. 2019 Apr;30(2):380-386. doi: 10.1007/s12028-018-0610-0. Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial. Ullman NL1, Tahsili-Fahadan P2,3, Thompson CB4, Ziai WC2, Hanley DF5. Author information...